We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Kit Screens for Neurite Outgrowth Neurotoxin Inducers and Inhibitors

By Biotechdaily staff writers
Posted on 20 Aug 2007
A new assay kit uses high-content screening for imaging and analysis of neurite outgrowth and neuronal cell morphology.

The kit utilizes high-quality, validated, target-specific detection reagents for profiling in a variety of species, including human, mouse, and rat. Large-scale screening is simplified because the assay reagents are stable for 24-hours at room temperature.

The primary antibody is immunofluorescence-based to specifically label neurites and neuronal cell bodies in heterogeneous cell populations. High sensitivity-generating images with high signal-to-background ratios facilitate subsequent high content analysis, making the kit suitable for screening both inducers and inhibitors of neurite outgrowth neurotoxins.

Developed by Millipore corp. (Billerca, MA, USA), the new kit is called the Neurite Outgrowth assay. It is the newest assay kit in Millipore's drug discovery product line.

Millipore's Bioscience Division provides tools, services, and biologic reagents for LifeSciences and supports the discovery and development of new pharmaceuticals. Its product portfolio was enhanced in 2006 by the addition of the Chemicon, Upstate, and Linco product lines.


Related Links:
Millipore

Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Electrolyte Analyzer
BKE-B

Latest BioResearch News

New Findings Clarify Molecular Drivers of Rare Small Intestinal Cancer
20 Aug 2007  |   BioResearch

Lung Cancer Study Reveals Cellular Program Behind Therapy Resistance
20 Aug 2007  |   BioResearch

Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers
20 Aug 2007  |   BioResearch



ADLM